Review the important dates below for 2024 IKCS: Europe
|Abstract Submissions Open!
|December 14, 2023
|Program-At-A-Glance Coming Soon!
|Registration Now Open
|Hotel Reservation Information
|Program Details and Speakers Released
|Abstract Submission Deadline
SUBMIT AN ABSTRACT NOW!
(all complete Regular, TPS, and Case Report submissions, and all LBA Placeholders due at this time)
|February 8, 2024
|LBA Submission Deadline (LBA Placeholder required by February 2, 2024, deadline)
|February 29, 2024, (placeholder required by February 8, 2024)
|Abstract Notifications Sent to Lead Authors
|March 7, 2024
|Early Symposium Registration Deadline
|March 23, 2024
|Abstract Withdrawal Deadline
(Withdrawal requests must be submitted by the Lead Author to [email protected])
|March 21, 2024
|Abstract Titles Released
|March 28, 2024
|Deadline to cancel Hotel Reservations without fees
|Less than 14 days before the arrival the full cost of the stay will be charged to the credit card provided at time of reservation, as a cancellation cost.
|Presentation Slides Due
|March 22, 2024
|Poster Uploads Due
|April 4, 2024
|Full Abstracts Released
|April 16, 2024 at 16:00 ET
|Post-Meeting On Demand Available
|Beginning of May 2024
|April 18 – 20, 2024
|Hotel Cut-off for group rate date
|April 1, 2024
|Early Registration Rate (Register by March 23, 2024 at 23:59 GMT)
|Regular Registration Rate (After March 23, 2024)
|Post-Event (April 25, 2024 to December 31, 2024)
|Group In-person Physician/Scientist (this rate includes 1 in-person Physician/Scientist registration and 3 post-meeting on-demand access registrations)
|In-person Allied Health Professional
|In-person Physician In-Training
|Post-Event On-Demand Access
Meeting Venue: Meliá Sitges
Venue Address: Joan Salvat Papasseit, 38, Sitges, 08870 Spain
Booking Policy: Support the KCA and Save with Our Host Hotel! – Exclusive Benefits for Event Attendees:
Special Room Rates: Enjoy discounted rates when you book your guest room at our host hotel forIKCSEU24. We’ve negotiated rates lower than the standard, ensuring you get the best value for your stay.
Supporting the KCA: By choosing our host hotel, you’re directly contributing to the Kidney Care Association (KCA). Your reservation helps fund patient and healthcare professional programs. The KCA is committed to filling our room block. Unfulfilled rooms become a financial responsibility. Your decision to stay with us ensures resources go where they’re needed most.
Revenue Impact: In the spirit of transparency, we want to emphasize that falling short of our revenue goals affects not only the current event but future ones as well. If we don’t meet our targets, subsequent event registration fees may need adjustments to cover lost revenue.
Follow the guidelines below to submit an abstract to IKCS: Europe.
ABSTRACT SUBMISSION TYPES:
PUBLICATION OF CONFERENCE PROCEEDINGS:
Following symposia participation, authors may be asked to contribute a concise manuscript for potential inclusion in a dedicated Kidney Cancer publication. Stay tuned for forthcoming details.
Abstracts in the following categories will be considered for presentation:
Late-Breaking Data Submission Guidelines
Abstracts submitted in this category are Phase I-IV trials, or original research that could impact practice and standard of care. LBAs should be studies where results and conclusions are not yet available by the February 8 deadline, but will be available by the February 29, 2024 deadline.
Abstracts submitted in this category must have a placeholder submission (all components except for Results and Conclusions sections) received by the February 8, 2024 abstract submission deadline.
Lead authors will receive separate instructions to complete LBA placeholder submissions by February 15, 2024.
Trials-In-Progress Abstract Submission Guidelines
Abstracts submitted in this category are ongoing and should not include data, results, nor conclusions.
TIP abstracts are open, enrolling, or ongoing and have not reached any protocol-specific endpoints for analysis, and consequently will only require the completion of the Background and Methods sections.
Abstracts in all phases of clinical research (I, II, III, IV) may be submitted.
TIP Abstracts, if accepted, are eligible for Poster Presentation. TIP abstracts are not eligible for Oral Presentation.
IKCS Meetings seek to highlight cutting edge research; therefore, submissions should reflect unpublished work. Encore Data is still accepted for submission under any of the abstract categories only if a novel aspect of that research is presented. If you feel your work is derivative, but still has novelty merits, highlight this fact and be clear about what advancements you made. The program committee maintains the ultimate discretion to accept or reject encore abstracts. Abstracts presented at past IKCS meetings will not be accepted.
Abstracts will be reviewed by the IKCS: Europe Scientific Planning Committee. Abstract notifications will be sent to lead authors in March 7, 2024,
All award winners will be notified by March 7, 2024. All abstracts submitted will automatically be eligible for a Merit Award.
Merit Awards are given to abstract authors who submit high-quality abstracts. Winners must be enrolled and in good standing in an oncology or urology training program, fellowship, or post-doctoral researcher position.
Merit Award Eligibility Requirements:
The IKCS Scientific Planning Committee will select four recipients to receive a merit award for the best original submissions.
All four winners will receive a complimentary registration to IKCS 2024 Europe, be recognized in the program booklet and on stage, and provided a speaking slot during the oral abstract session.
Top Rated Posters
Top rated poster awards are given to the top five posters after Merit Award selection. The organizing committee will select the top five posters. One presenter from each of the five abstracts selected must attend the Symposium to receive the award. Poster Ads Presenters will be selected from all abstracts to prepare a 2-minute PPT presentation (2 slides max) to succinctly showcase and promote the poster on Friday, April 19, 2024 at the IKCSEU24.
Top Rated Poster Award Eligibility Requirements:
The IKCS Scientific Planning Committee will select five recipients to receive a merit award for the best original submissions.
All winners will be recognized in the program booklet, be selected for poster ads on stage (2-min ad to the main conference audience) and will receive a TOP ABSTRACT/POSTER ribbon.
Outstanding Visual Design Poster
Will be assigned on site. Requirements: posters Must be up before 12pm on Friday April 19.
Planning committee selects on-site before the poster walk.
All Outstanding Visual Design Posters will receive recognition at the symposium.
All accepted abstracts and lead authors are required to present in-person at 2024 IKCS: Europe in Sitges, Spain. Accepted abstracts will be displayed at the live meeting and electronic versions will be available online.
All Abstract Presenters must register for the conference.
Abstract Release Information
Abstract titles will be released to the media March 28, 2024.
Poster Presentations will become available: April 16, 2024
PDF versions of presentation slides will become available during the specific session for the presentation.
Abstract submission closes February 15, 2024,
Please contact [email protected].
Thank you to our 2024 IKCS: Europe Planners!
Faculty Disclosures coming soon!
Speaker PPT Slide Presentations are due in the Faculty/Speaker Portal by March 22, 2024.
Meeting Format: 2024 IKCS: Europe will be a live event offering in-person participation for meeting attendees. On-demand access will be available post-meeting. Sessions will be recorded, but will not be live-streamed. Faculty are expected to attend in-person in.
Conflict of Interest Disclosure: Confirmation of any faculty invitation requires agreement to abide by Conflict of Interest procedures in addition to policies set forth by the Kidney Cancer Association, The France Foundation, and the Accreditation Council for Continuing Medical Education (ACCME) for content and presentation. All Faculty are required to submit a full disclosure of financial interests with commercial entities. All Conflict of Interest Disclosures will be reviewed by The France Foundation for final approval and participation in the program. Failure to submit a Conflict of Interest Disclosure will prohibit participation in the program.
Session Preparation: Speakers should upload their presentation slides by 22 March 2024. Slides will be reviewed by Session Chairs/Moderators and CME regulators to ensure compliance with CME guidelines, minimize content overlap between sessions, and help presentations contribute to a cohesive and educational session. Speakers may receive recommendations for slide adjustments. Speakers who are only able to participate virtually will receive instructions to pre-record their presentations prior to the meeting, along with instructions to participate in the live panel Q+A at the end of the session.
Download the PPT Template– Available January 2024
Faculty Benefits: Faculty may be eligible for benefits including Registration, Hotel accommodation, and travel assistance. Faculty will receive details and instructions for meeting arrangements directly via email. If you have questions please contact [email protected].